nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—mammary gland—breast cancer	0.0548	0.179	CbGeAlD
Tyloxapol—LPL—nipple—breast cancer	0.0454	0.148	CbGeAlD
Tyloxapol—LPL—embryo—breast cancer	0.0374	0.122	CbGeAlD
Tyloxapol—LPL—pituitary gland—breast cancer	0.0248	0.0809	CbGeAlD
Tyloxapol—LPL—adipose tissue—breast cancer	0.0247	0.0805	CbGeAlD
Tyloxapol—LPL—female reproductive system—breast cancer	0.0227	0.074	CbGeAlD
Tyloxapol—LPL—adrenal gland—breast cancer	0.0221	0.0722	CbGeAlD
Tyloxapol—LPL—bone marrow—breast cancer	0.0214	0.0699	CbGeAlD
Tyloxapol—LPL—female gonad—breast cancer	0.0206	0.0674	CbGeAlD
Tyloxapol—LPL—endocrine gland—breast cancer	0.0192	0.0626	CbGeAlD
Tyloxapol—LPL—lymph node—breast cancer	0.0133	0.0433	CbGeAlD
Tyloxapol—LPL—Signaling Pathways—CCL20—breast cancer	0.000519	0.000748	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC2A2—breast cancer	0.000516	0.000745	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.000511	0.000737	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF3—breast cancer	0.000509	0.000734	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP2—breast cancer	0.000507	0.000731	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCG2—breast cancer	0.000506	0.000729	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CPT1A—breast cancer	0.000506	0.000729	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTR—breast cancer	0.000506	0.000729	CbGpPWpGaD
Tyloxapol—LPL—Disease—JAG1—breast cancer	0.000503	0.000725	CbGpPWpGaD
Tyloxapol—LPL—Disease—FASN—breast cancer	0.000503	0.000725	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TLE3—breast cancer	0.000503	0.000725	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LPAR1—breast cancer	0.000503	0.000725	CbGpPWpGaD
Tyloxapol—LPL—Disease—PARP1—breast cancer	0.000501	0.000722	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HEY1—breast cancer	0.000498	0.000717	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HPGDS—breast cancer	0.000496	0.000715	CbGpPWpGaD
Tyloxapol—LPL—Disease—CALCA—breast cancer	0.000494	0.000713	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HBA1—breast cancer	0.000493	0.000711	CbGpPWpGaD
Tyloxapol—LPL—Disease—RPS6—breast cancer	0.000489	0.000704	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DLL1—breast cancer	0.000488	0.000704	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF4—breast cancer	0.000485	0.000699	CbGpPWpGaD
Tyloxapol—LPL—Disease—CXCR4—breast cancer	0.000483	0.000696	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTT1—breast cancer	0.000481	0.000694	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ACHE—breast cancer	0.000481	0.000694	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIST1H2BC—breast cancer	0.000479	0.000691	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIST1H2BK—breast cancer	0.000479	0.000691	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC2A1—breast cancer	0.000478	0.000689	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GRB7—breast cancer	0.000475	0.000684	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDE4D—breast cancer	0.000475	0.000684	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TAB2—breast cancer	0.000466	0.000673	CbGpPWpGaD
Tyloxapol—LPL—Disease—TCF7L2—breast cancer	0.000466	0.000671	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CNR2—breast cancer	0.000463	0.000667	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP17A1—breast cancer	0.000456	0.000657	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DKK1—breast cancer	0.000451	0.000651	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS1—breast cancer	0.000451	0.00065	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ENO1—breast cancer	0.000451	0.00065	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000449	0.000648	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RAF1—breast cancer	0.000449	0.000648	CbGpPWpGaD
Tyloxapol—LPL—Disease—HSP90AA1—breast cancer	0.000449	0.000647	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFC—breast cancer	0.000448	0.000646	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RELA—breast cancer	0.000447	0.000645	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ERBB2—breast cancer	0.000444	0.000641	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.000444	0.00064	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2D6—breast cancer	0.000442	0.000638	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JAG2—breast cancer	0.000441	0.000636	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRL—breast cancer	0.000437	0.00063	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—WNT1—breast cancer	0.000435	0.000627	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NCOA2—breast cancer	0.000434	0.000626	CbGpPWpGaD
Tyloxapol—LPL—Disease—ADAM10—breast cancer	0.00043	0.000621	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—FASN—breast cancer	0.000421	0.000607	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—BCHE—breast cancer	0.000419	0.000604	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF10—breast cancer	0.000419	0.000604	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC5A5—breast cancer	0.000414	0.000597	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH4—breast cancer	0.000412	0.000594	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GZMB—breast cancer	0.00041	0.000591	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFA—breast cancer	0.000404	0.000583	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NQO1—breast cancer	0.0004	0.000577	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC2A1—breast cancer	0.0004	0.000577	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFBR2—breast cancer	0.000398	0.000574	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL2—breast cancer	0.000398	0.000574	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGTR2—breast cancer	0.000398	0.000574	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTHLH—breast cancer	0.000393	0.000567	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BMP2—breast cancer	0.000393	0.000567	CbGpPWpGaD
Tyloxapol—LPL—Disease—ITPR1—breast cancer	0.000392	0.000565	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.000392	0.000565	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP3A4—breast cancer	0.00039	0.000562	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB4—breast cancer	0.000389	0.000561	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT5A—breast cancer	0.000389	0.000561	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CTNNB1—breast cancer	0.000389	0.000561	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000388	0.000559	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP1B1—breast cancer	0.000383	0.000553	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP9—breast cancer	0.000381	0.00055	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDNRB—breast cancer	0.000381	0.000549	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PGR—breast cancer	0.000377	0.000544	CbGpPWpGaD
Tyloxapol—LPL—Disease—SMAD4—breast cancer	0.000377	0.000544	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HSP90AA1—breast cancer	0.000376	0.000542	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—THBS1—breast cancer	0.000375	0.000541	CbGpPWpGaD
Tyloxapol—LPL—Disease—HES1—breast cancer	0.000368	0.000531	CbGpPWpGaD
Tyloxapol—LPL—Disease—NCOR1—breast cancer	0.000366	0.000528	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NCOA1—breast cancer	0.000366	0.000527	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF1—breast cancer	0.000362	0.000522	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—STK11—breast cancer	0.00036	0.00052	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP19A1—breast cancer	0.00036	0.00052	CbGpPWpGaD
Tyloxapol—LPL—Disease—NRG1—breast cancer	0.000359	0.000518	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FLT1—breast cancer	0.000358	0.000516	CbGpPWpGaD
Tyloxapol—LPL—Disease—H2AFX—breast cancer	0.000357	0.000514	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF3—breast cancer	0.000357	0.000514	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SQSTM1—breast cancer	0.000357	0.000514	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JAG1—breast cancer	0.000352	0.000508	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SRC—breast cancer	0.000351	0.000507	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PARP1—breast cancer	0.000351	0.000505	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH3—breast cancer	0.000351	0.000505	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CALCA—breast cancer	0.000346	0.000499	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERCC2—breast cancer	0.000344	0.000496	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—breast cancer	0.000342	0.000493	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RPS6—breast cancer	0.000342	0.000493	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF4—breast cancer	0.000339	0.00049	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—STAT3—breast cancer	0.000339	0.000489	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTEN—breast cancer	0.000338	0.000488	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCR4—breast cancer	0.000338	0.000488	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL12—breast cancer	0.000338	0.000488	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB3—breast cancer	0.000337	0.000485	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGFR2—breast cancer	0.000336	0.000485	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—COMT—breast cancer	0.000335	0.000483	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTP1—breast cancer	0.000334	0.000481	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PAK1—breast cancer	0.000332	0.000479	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMOX1—breast cancer	0.000329	0.000474	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ITPR1—breast cancer	0.000328	0.000473	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TCF7L2—breast cancer	0.000326	0.00047	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAPK3—breast cancer	0.000324	0.000467	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTHFR—breast cancer	0.000323	0.000466	CbGpPWpGaD
Tyloxapol—LPL—Disease—TERT—breast cancer	0.000323	0.000465	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCB1—breast cancer	0.000316	0.000455	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HSP90AA1—breast cancer	0.000314	0.000453	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH2—breast cancer	0.000314	0.000453	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TGFB1—breast cancer	0.000314	0.000453	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGFR1—breast cancer	0.000313	0.000452	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TYMS—breast cancer	0.00031	0.000447	CbGpPWpGaD
Tyloxapol—LPL—Disease—HIF1A—breast cancer	0.000308	0.000445	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EGFR—breast cancer	0.000308	0.000444	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTM1—breast cancer	0.000307	0.000442	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PLA2G4A—breast cancer	0.000307	0.000442	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NCOR1—breast cancer	0.000307	0.000442	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGTR1—breast cancer	0.000306	0.000441	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRL—breast cancer	0.000306	0.000441	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STK11—breast cancer	0.000301	0.000435	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADAM10—breast cancer	0.000301	0.000435	CbGpPWpGaD
Tyloxapol—LPL—Disease—CAV1—breast cancer	0.000298	0.00043	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PLG—breast cancer	0.000298	0.00043	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GPX1—breast cancer	0.000294	0.000423	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—breast cancer	0.000293	0.000423	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF10—breast cancer	0.000293	0.000423	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KRAS—breast cancer	0.000291	0.00042	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP1A1—breast cancer	0.000291	0.000419	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ERCC2—breast cancer	0.000288	0.000416	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFA—breast cancer	0.000283	0.000408	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS2—breast cancer	0.000281	0.000405	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFBR2—breast cancer	0.000279	0.000402	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOTCH1—breast cancer	0.000278	0.000401	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ITPR1—breast cancer	0.000274	0.000396	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT5A—breast cancer	0.000273	0.000393	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP3—breast cancer	0.000273	0.000393	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB4—breast cancer	0.000273	0.000393	CbGpPWpGaD
Tyloxapol—LPL—Disease—APC—breast cancer	0.000272	0.000392	CbGpPWpGaD
Tyloxapol—LPL—Disease—KIT—breast cancer	0.000272	0.000392	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTHFR—breast cancer	0.000271	0.000391	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGF—breast cancer	0.000269	0.000387	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SMAD4—breast cancer	0.000264	0.000381	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1R—breast cancer	0.000262	0.000378	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HES1—breast cancer	0.000258	0.000372	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PLA2G4A—breast cancer	0.000256	0.00037	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NCOR1—breast cancer	0.000256	0.00037	CbGpPWpGaD
Tyloxapol—LPL—Disease—BRAF—breast cancer	0.000255	0.000368	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF1—breast cancer	0.000253	0.000365	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CSF2—breast cancer	0.000253	0.000365	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NRG1—breast cancer	0.000252	0.000363	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CAV1—breast cancer	0.00025	0.00036	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—H2AFX—breast cancer	0.00025	0.00036	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT2—breast cancer	0.000249	0.000359	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—E2F1—breast cancer	0.000248	0.000358	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HRAS—breast cancer	0.000247	0.000357	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CD—breast cancer	0.000239	0.000344	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	0.000239	0.000344	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SPP1—breast cancer	0.000238	0.000344	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6—breast cancer	0.000237	0.000341	CbGpPWpGaD
Tyloxapol—LPL—Disease—SERPINE1—breast cancer	0.000236	0.000341	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB3—breast cancer	0.000236	0.00034	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGFR2—breast cancer	0.000235	0.000339	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CG—breast cancer	0.000228	0.000328	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TERT—breast cancer	0.000226	0.000326	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS3—breast cancer	0.000226	0.000325	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGFR1—breast cancer	0.000219	0.000316	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT1—breast cancer	0.000218	0.000315	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIF1A—breast cancer	0.000216	0.000311	CbGpPWpGaD
Tyloxapol—LPL—Disease—MDM2—breast cancer	0.000214	0.000309	CbGpPWpGaD
Tyloxapol—LPL—Disease—RAF1—breast cancer	0.000213	0.000308	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB2—breast cancer	0.000211	0.000304	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LEP—breast cancer	0.000211	0.000304	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CAV1—breast cancer	0.000209	0.000301	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CB—breast cancer	0.000208	0.0003	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTOR—breast cancer	0.000208	0.0003	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD4—breast cancer	0.000208	0.0003	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KDR—breast cancer	0.000207	0.000298	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—breast cancer	0.000206	0.000298	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ESR1—breast cancer	0.000201	0.00029	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CD—breast cancer	0.0002	0.000289	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FN1—breast cancer	0.000199	0.000287	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALB—breast cancer	0.000198	0.000285	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NFKBIA—breast cancer	0.000197	0.000283	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1B—breast cancer	0.000195	0.000282	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH1—breast cancer	0.000195	0.000281	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CG—breast cancer	0.00019	0.000274	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APC—breast cancer	0.00019	0.000274	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KIT—breast cancer	0.00019	0.000274	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NOS3—breast cancer	0.000189	0.000272	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGF—breast cancer	0.000188	0.000271	CbGpPWpGaD
Tyloxapol—LPL—Disease—CTNNB1—breast cancer	0.000185	0.000266	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1A—breast cancer	0.00018	0.00026	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTEN—breast cancer	0.00018	0.000259	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BRAF—breast cancer	0.000179	0.000258	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CB—breast cancer	0.000174	0.000251	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1—breast cancer	0.000174	0.000251	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT2—breast cancer	0.000174	0.000251	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—breast cancer	0.000173	0.000249	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CD—breast cancer	0.000167	0.000241	CbGpPWpGaD
Tyloxapol—LPL—Disease—SRC—breast cancer	0.000167	0.000241	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SERPINE1—breast cancer	0.000165	0.000239	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT3—breast cancer	0.000161	0.000232	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOS3—breast cancer	0.000158	0.000228	CbGpPWpGaD
Tyloxapol—LPL—Disease—MAPK3—breast cancer	0.000154	0.000222	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTEN—breast cancer	0.000151	0.000217	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MDM2—breast cancer	0.00015	0.000216	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—breast cancer	0.00015	0.000216	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RAF1—breast cancer	0.000149	0.000215	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFB1—breast cancer	0.000149	0.000215	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RELA—breast cancer	0.000149	0.000214	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB2—breast cancer	0.000148	0.000213	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGFR—breast cancer	0.000146	0.000211	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MTOR—breast cancer	0.000146	0.00021	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CB—breast cancer	0.000146	0.00021	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL8—breast cancer	0.00014	0.000202	CbGpPWpGaD
Tyloxapol—LPL—Disease—KRAS—breast cancer	0.000138	0.000199	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1B—breast cancer	0.000137	0.000197	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASP3—breast cancer	0.000134	0.000193	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL2—breast cancer	0.000134	0.000193	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCND1—breast cancer	0.000131	0.000188	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JUN—breast cancer	0.00013	0.000188	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CTNNB1—breast cancer	0.000129	0.000186	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CA—breast cancer	0.000127	0.000183	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP9—breast cancer	0.000127	0.000183	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1A—breast cancer	0.000126	0.000182	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTEN—breast cancer	0.000126	0.000182	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK8—breast cancer	0.000123	0.000178	CbGpPWpGaD
Tyloxapol—LPL—Disease—HRAS—breast cancer	0.000117	0.000169	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SRC—breast cancer	0.000117	0.000169	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—breast cancer	0.000114	0.000164	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT3—breast cancer	0.000113	0.000162	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6—breast cancer	0.000112	0.000162	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK3—breast cancer	0.000108	0.000155	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CA—breast cancer	0.000106	0.000153	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—breast cancer	0.000105	0.000151	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFB1—breast cancer	0.000104	0.000151	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT1—breast cancer	0.000104	0.00015	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGFR—breast cancer	0.000102	0.000148	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KRAS—breast cancer	9.68e-05	0.00014	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CA—breast cancer	8.89e-05	0.000128	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKT1—breast cancer	8.68e-05	0.000125	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—breast cancer	8.6e-05	0.000124	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HRAS—breast cancer	8.22e-05	0.000119	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6—breast cancer	7.87e-05	0.000114	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT1—breast cancer	7.26e-05	0.000105	CbGpPWpGaD
